KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.19+0.00 (+1.42%)
Close on Oct 19, 2026Market cap $14.28KP/E –Yield –
Kala Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Kala Bio's free cash flow for the twelve months ending Sep 30, 2020 was -$84.63M. For fiscal 2019 it was -$94.06M. The highest annual figure on record is -$15.34M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$94.06M | – |
| FY2018 | Dec 31, 2018 | -$55.70M | – |
| FY2017 | Dec 31, 2017 | -$34.58M | – |
| FY2016 | Dec 31, 2016 | -$27.50M | – |
| FY2015 | Dec 31, 2015 | -$15.34M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -$26.19M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$20.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$23.12M | – |
| Q2 FY2019 | Jun 30, 2019 | -$20.93M | – |
| Q1 FY2019 | Mar 31, 2019 | -$31.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.34M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$13.09M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.85M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$9.43M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.39M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.19M | – |
See a number that looks wrong?